Statins may help prevent diabetes-related eye problems

Cannabis, Life Science

New opioid-alternative raises $3.25 million for Phase I trials

Life Science

Marijuana grower Tilray soars more than 20% after Peter Thiel-backed fund says it won’t sell

Cannabis, Life Science

Medbanks Closes $59 Million D Round for China Oncology Database

Life Science

Alibaba, Unittec to Work Together on Smart City Solutions

Life Science

LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic Partnership to Offer Leading Clinical NGS Solution to the China Market

Life Science

Aslan Pharma OK’d to Start US Arm of Phase II Trial of AML Treatment

Life Science

Everest Medicines Signs $61.5 Million Deal for Drug Resistant Antibiotic

Life Science

Bevo and Sun Pharm Complete Reverse Takeover to Become Zenabis Global Inc.

Cannabis, Life Science

Fosun Pharma Selects ArisGlobal’s LifeSphere (R) Safety MultiVigilance Solution Suite to Support Its Global Pharmacovigilance Strategy

Life Science

Ascentage Out-Licenses Candidate for Age-Related Eye Disease to Unity Bio

Life Science

Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Targeting Multiple Myeloma (MM)

Life Science

Oramed Receives Additional $3 Million Milestone Payment from HTIT

Life Science

Canadian pot shortage could last up to three years, industry executives say

Cannabis, Life Science

Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing

Life Science